Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableUnknownNCT00220506
What this trial is testing

Fatigue Treatment Using Provigil

Who this might be right for
All Multiple Sclerosis Patients
Sheba Medical Center 50
Not applicableNot Yet RecruitingNCT07647952
What this trial is testing

PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple Sclerosis

Who this might be right for
Relapsing - Remitting Multiple Sclerosis
Nantes University Hospital 448
Testing effectiveness (Phase 2)Looking for participantsNCT03910738
What this trial is testing

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Strasbourg, France 40
Early research (Phase 1)Ended earlyNCT01808482
What this trial is testing

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 16
Not applicableStudy completedNCT05423769
What this trial is testing

Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Hikma Pharmaceuticals LLC 30
Not applicableStudy completedNCT05438693
What this trial is testing

Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
doaa mokhtar mahmoud 80
Not applicableStudy completedNCT05684016
What this trial is testing

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
George Washington University 75
Early research (Phase 1)Study completedNCT01416363
What this trial is testing

Healthy Volunteer Study Using 3 Different Formulations of Firategrast

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07263607
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Sichuan Academy of Medical Sciences 80
Early research (Phase 1)Study completedNCT02398461
What this trial is testing

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Who this might be right for
Multiple Sclerosis, Acute Relapsing
Acorda Therapeutics 27
Not applicableStudy completedNCT05175378
What this trial is testing

Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study

Who this might be right for
Multiple Sclerosis
Iaso Maternity Hospital, Athens, Greece 40
Not applicableStudy completedNCT03497468
What this trial is testing

Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bezmialem Vakif University 34
Not applicableStudy completedNCT04997148
What this trial is testing

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 116
Not applicableStudy completedNCT01628315
What this trial is testing

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
University at Buffalo 159
Not applicableStudy completedNCT01804647
What this trial is testing

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease

Who this might be right for
Multiple Sclerosis (MS)Relapsing-Remitting MSPrimary Progressive MS+2 more
GeNeuro Innovation SAS 58
Not applicableStudy completedNCT03000647
What this trial is testing

Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisUrinary Incontinence
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 48
Not applicableStudy completedNCT05367947
What this trial is testing

In-phase Bilateral Exercises in People With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Cyprus University of Technology 5
Testing effectiveness (Phase 2)Study completedNCT02782858
What this trial is testing

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GeNeuro SA 270
Large-scale testing (Phase 3)Study completedNCT01442233
What this trial is testing

Plasma Exchanges in Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Acute Relapsing
University Hospital, Bordeaux 38
Next Page